| TGA Action ID |
RC-2026-RN-00629-1 |
| Type of Product |
Medicine |
| Product Name/Description |
Pertuzumab 420mg in 0.9% Sodium Chloride in Polyolefin Bag (Freeflex) for Intravenous Infusion
Batch Number: BB26084718
Expiry Date: 07/08/2026
ARTG Exempt |
| ARTG Number |
|
| Action Type |
Recall |
| Action Level |
Hospital |
| Hazard Classification |
Class II |
| Reason for the Action |
Cairns Hospital reported on 11/08/2026 that a Pertuzumab infusion bag (BB26084718) had expired prior to treatment. The single dose unit had expired during transit to the customer. The customer advised the single dose unit was not administrated and discarded. A replacement unit was provided to the customer. This recall does not affect any other compounded batches of Pertuzumab or any other Slade Health products.
Given the nature of the product, this action was undertaken prior to TGA notification (Immediate Market Action as defined within the PRAC). |
| Instructions for Customers/Users |
- The product has been discarded by the customer.
- A replacement product has been provided to the customer. |
| Action Commencement Date |
17/08/2026 |
| Responsible Entity |
|
| Contact Information |
03 9565 4300 - Slade Health Head Office |